1. Kong X#, Chen J#, Xie W#, Brown S, Cai Y, Wu K, Fan D, Nie Y, Yegnasubramanian S, Tiedemann R, Tao Y, Yen R, Topper MJ, Easwaran H, Rothbart SB*, Xia L*, Baylin SB*, Defining UHRF1 Domains That Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties, Cancer Cell. 2019;35(4):633-648
2. Kong X#, Liu J#, Li L, Yue L, Zhang L, Jiang H, Xie X*, Luo C*, Functional interplay between the RK motif and linker segment dictates Oct4-DNA recognition, Nucleic Acids Res. 2015;43(9):4381-92
3. Kong X#, Chen L#, Jiao L, Jiang X, Lian F, Lu J, Zhu K, Du D, Liu J, Ding H, Zhang N, Shen J, Zheng M, Chen K, Liu X, Jiang H, Luo C*. Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2, J Med Chem. 2014;57(22):9512-21
4. Ye F#, Kong X#, Zhang H, Liu Y, Shao Z, Jin J, Cai Y, Zhang R, Li L, Zhang YW, Liu YC, Zhang C, Xie W, Yu K, Ding H, Zhao K, Chen S, Jiang H*, Baylin SB*, Luo C*. Biochemical Studies and Molecular Dynamic Simulations Reveal the Molecular Basis of Conformational Changes in DNA Methyltransferase-1, ACS Chem Biol. 2018;13(3):772-781
5. Zhu M#, Du D#, Hu J, Li L, Liu J, Ding H, Kong X*, Jiang H, Chen K, Luo C*, Development of a high-throughput fluorescence polarization assay for the discovery of EZH2-EED interaction inhibitors, Acta Pharmacol Sin. 2018;39(2):302-310 （co-corresponding）
